Percutaneous septal ablation in hypertrophic obstructive cardiomyopathy: Long-term follow-up;Langzeitverlauf nach perkutaner septumablation bei hypertropher obstruktiver kardiomyopathie

Deutsche Medizinische Wochenschrift

Volumn 133, Issue 39, 2008, Pages 1949-1954

  Welge, D ^a   Seggewiss, H ^b   Fassbender, D ^a   Schmidt, H K ^a   Horstkotte, D ^a   Faber, Lothar ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Leopoldina Krankenhaus   (Germany)

Author keywords

DDD pacemaker; Hypertrophic obstructive cardiomyopathy; ICD; Percutaneous transluminal septal myocardial ablation; Risk stratification

Indexed keywords

ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FOLLOW UP; HEART SURGERY; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MORBIDITY; MORTALITY; PERCUTANEOUS SEPTAL ABLATION; TREATMENT OUTCOME; CATHETER ABLATION; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; HYPERTROPHIC CARDIOMYOPATHY; MALE; MIDDLE AGED; STRESS ECHOCARDIOGRAPHY; VALSALVA MANEUVER;

CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, STRESS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; VALSALVA MANEUVER;

EID: 52149106651     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1085601     Document Type: Article

References (35)

1. Alam M, Dokainish H, Lakkis N. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: A systematic review of published studies. J Interven Cardiol 2006; 19: 319-327
2. Bender R, Grouven U, Ziegler A. Varianzanalyse für Messwertwiederholungen. Dtsch Med Wschr 2007; 132: e61-64
3. Baggish AL, Smith RN, Palacios I et al. Pathological effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Heart 2006; 92: 1773-1778
4. Bauer F, Shiota T, White RD et al. Determinant of left atrial dilation in patients with hypertrophic cardiomyopathy: A real-time 3-dimensional echocardiographic study. J Am Soc Echocardiogr 2004; 17: 968-975
5. Brunner-La Schonbeck MH, Rocca HP, Vogt PR et al. Long-term follow-up in hypertrophic obstructive cardiomyopathy after septal myectomy. Ann Thorac Surg 1998; 65: 1207-1214
6. Elliott PM, Poloniecki J, Dickie S et al. Sudden death in HCM: Identification of high risk patients. J Am Coll Cardiol 2000; 36: 2212-2218
7. Faber L, Meissner A, Ziemssen P, Seggewiss H. Percutaneous transluminal septal myocardial ablation for HOCM: Long-term follow-up in the first series of 25 patients. Heart 2000; 83: 326-331
8. Faber L, Seggewiss H, Gleichmann U. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Results with respect to intra-procedural myocardial contrast echocardiography. Circulation 1998; 98: 2415-2421
9. Faber L, Seggewiss H, Ziemssen P. Targeting percutaneous transluminal septal ablation for HOCM by intra-procedural echocardiographic monitoring. J Am Soc Echocardiogr 2000; 13: 1074-1079
10. Fernandes VL, Nagueh SF, Wang R et al. A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: The Baylor experience (1996-2002). Clin Cardiol 2005; 28: 124-130
11. Firoozi S, Elliott PM, Sharma S et al. Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. Eur Heart J 2002; 23: 1617-1624
12. Gietzen FH, Leuner CJ, Raute-Kreinsen et al. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Eur Heart J 1999; 20: 1342-1354
13. Guo H, Wang J, Chen J et al. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and three-year noninvasive follow-up in 18 patients. Can J Cardiol 2004; 8: 779-782
14. Jassal DS, Neilan TG, Fifer MA et al. Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Eur Heart J 2006; 27: 1805-1810
15. Kimmelstiel CD, Maron BJ. Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy. Circulation 2004; 109: 452-456
16. Kuhn H, Seggewiss H, Gietzen FH et al. Catheter-based therapy for hypertrophic obstructive cardiomyopathy. First in-hospital outcome analysis of the German TASH registry. Z Kardiol 2004; 93: 23-31
17. Lawrenz T, Obergassel L, Lieder F. Transcoronary ablation of septal hypertrophy does not alter ICD intervention rates in high risk patients with hypertrophic obstructive cardiomyopathy. PACE 2005; 28; 295-300
18. Maron BJ. Surgery for hypertrophic obstructive cardiomyopathy. Circulation 2005; 111: 2016-2018
19. Maron BJ, McKenna WJ, Danielson GK et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003; 42: 1687-1713
20. McCully RB, Nishimura RA, Tajik AJ et al. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. Circulation 1996; 94: 467-471
21. Merrill WH, Friesinger GC, Graham TP et al. Long-lasting improvement after septal myectomy for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg 2000; 69: 1732-1735
22. Minami K, Boethig D, Woltersdorf H et al. Long term follow-up of surgical treatment of hypertrophic obstructive cardiomyopathy (HOCM): the role of concomitant cardiac procedures. Eur J Cardiothorac Surg 2002; 22: 206-210
23. Morrow AG, Brockenbrough EC. Surgical treatment of idiopathic hypertrophic subaortic stenosis: Technique and hemodynamic results of subaortic ventriculotomy. Ann Surg 1961; 154: 181-189
24. Nagueh SF, Ommen SR, Lakkis NM et al. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2001; 38: 1707-1710
25. Ommen SR, Maron BJ, Olivotto I et al. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2005; 46: 470-476
26. Pedone C, Biagini E, Galema TW et al. Myocardial perfusion after percutaneous septal ablation as assessed by myocardial contrast echocardiography with hypertrophic obstructive cardiomyopathy. J Am Soc Echocardiogr 2006; 19: 982-986
27. Qin JX, Shiota T, Lever HM et al. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol 2001; 38: 1994-2000
28. Robbins RC, Stinson EB, Daily PO. Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg 1996; 111: 586-594
29. Schulte HD, Bircks W, Lösse B. Techniques and complications of transaortic subvalvular myectomy in patients with hypertrophic obstructive cardiomyopathy (HOCM). Z Kardiol 1987; 76 (supp. 3): 145-151
30. Schulte HD, Gramsch-Zabel H, Schwartzkopff B. Hypertrophische obstruktive Kardiomyopathie: Chirurgische Behandlung. Schweiz Med Wochenschr 1995; 125: 1940-1949
31. Seggewiss H, Gleichmann V, Faber L et al. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and 3-months follow-up in 25 patients. J Am Coll Cardiol 1998; 31: 252-258
32. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995; 346: 211-214
33. Sitges M, Shiota T, Lever HM et al. Comparison of left ventricular diastolic function in obstructive hypertrophic cardiomyopathy in patients undergoing percutaneous septal alcohol ablation versus surgical myotomy/myectomy. Am J Cardiol 2003; 91: 817-821
34. Woo A, Williams WG, Choi R et al. Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy. Circulation 2005; 111: 2033-2041
35. Yu EH, Omran AS, Wigle ED et al. Mitral regurgitation in hypertrophic obstructive cardiomyopath: relationship to obstruction and relief with myectomy. J Am Coll Cardiol 2000; 36: 2219-225